Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06971640 · ClinicalTrials.gov registry record
Advancing Identification of Circadian Delay in ADHD Youth: Associations With Clinical Heterogeneity and Cognition
A clinical trial of ADHD and ADHD - Attention Deficit Disorder With Hyperactivity, sponsored by Duke University.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT06971640: Recruiting study of ADHD and ADHD - Attention Deficit Disorder With Hyperactivity, sponsored by Duke University.
NCT06971640 is a study of ADHD and ADHD - Attention Deficit Disorder With Hyperactivity that is actively recruiting participants, run by Duke University. The registered enrollment target is 250 participants, above the 187-participant average among 75 other ADHD trials with a reported enrollment target (34% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06971640, a study of ADHD and ADHD - Attention Deficit Disorder With Hyperactivity, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to better understand sleep and circadian functioning in children with ADHD using home-based measures, parent report, and a lab based melatonin assessment. Investigators will also examine how sleep relates to psychiatric health and cognition among children with ADHD. The investigator for this study is Dr. Jessica Lunsford-Avery from the Department of Psychiatry.
Primary Outcome
Wearable sensor data collection includes 3 sensors and supporting materials. The GreenTEG Core sensor will measure changes in core body temperature (CBT) beginning each evening and continuing through the night until morning waking. The Withings Mat will index times in/out of bed and related sleep metrics. The Garmin Vivosmart 5 will continuously measure movement and heart rate.
Conditions Studied
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2025-05-28 |
| Est. Completion | 2029-11 |
What NCT06971640 shows while recruiting
NCT06971640 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 187-participant average among 75 other ADHD trials with a reported enrollment target (34% higher).
The record links to 2 conditions, with ADHD appearing as the primary indexed condition, and to 0 interventions.
NCT06971640 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06971640 about?
NCT06971640 is a clinical study titled "Advancing Identification of Circadian Delay in ADHD Youth: Associations With Clinical Heterogeneity and Cognition". The purpose of this study is to better understand sleep and circadian functioning in children with ADHD using home-based measures, parent report, and a lab based melatonin assessment. Investigators will also examine how sleep relates to psychiatric health and cognition among children with ADHD. The ...
What is the current status of trial NCT06971640?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2025-05-28. Estimated completion is 2029-11.
What conditions does trial NCT06971640 study?
This clinical trial studies the following conditions: ADHD, ADHD - Attention Deficit Disorder With Hyperactivity.
Who is sponsoring clinical trial NCT06971640?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06971640 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06971640's enrollment target sits among peer trials
250 17th of 75 higher than 59 of 75 other ADHD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Target ADHD Executive Working Memory Replication Study
RECRUITING · NA
-
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
RECRUITING · Phase 4
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Evaluating Treatment of ADHD in Children with Down Syndrome
RECRUITING · Phase 4
-
Fidgeting and Attentional and Emotional Regulation in ADHD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI